Paclitaxel (albumin-bound)
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Paclitaxel (albumin-bound), covering 2019-07-16 to 2024-04-02. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer [Phase 3]